trending Market Intelligence /marketintelligence/en/news-insights/trending/C319AxAEomvT0mzc2f9-JA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Smiths Medical ASD recalls syringe pump due to software issue

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Smiths Medical ASD recalls syringe pump due to software issue

Smiths Medical ASD Inc. recalled its Medfusion 4000 syringe pump after its latest software update introduced an issue with the device.

The recent update to the syringe pump, which is used to administer blood and medicine into patients in a controlled manner, can potentially stop the syringe, giving low battery notifications to users.

The U.S. Food and Drug Administration has tagged the recall as class I, known as the most serious type of recall, as any interruption in therapy using the syringe can cause serious injury, adverse events or death.

The Weston, Mass.-based medical-device maker received 74 complaints regarding the software issue. No deaths or injuries have been reported.